Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari...

Wed, Apr 15

Perspectives

Nice to see M&A activity picking up in the sector. Safari is 59,000 sq ft, 6,000 KG per annum, had approximately $25M of debt, and sold for $26.5M. For context, Avant produced double that in FY2025, currently $1.5M of debt. Albeit, Safari has EU-GMP. Still, the disconnect

7382

/CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to...

Discover